{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:44:12Z","timestamp":1791870252183,"version":"4.3.4"},"reference-count":337,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["zyyzdxk-2023272"],"award-info":[{"award-number":["zyyzdxk-2023272"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"award":["zyyzdxk-2023272"],"award-info":[{"award-number":["zyyzdxk-2023272"]}],"id":[{"id":"https:\/\/ror.org\/003cpqh10","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, and residual inflammatory risk persists despite optimal lipid and glucose control. Emerging evidence indicates that metabolic reprogramming within immune cells constitutes a central driver of cardiovascular immune injury. In this review, we propose a unifying framework in which glyco-lipotoxicity acts as a primary metabolic trigger, inducing mitochondrial dysfunction, oxidative stress, and activation of the NLRP3 inflammasome and cGAS\u2013STING pathways. Hyperglycaemia and dyslipidaemia reshape intracellular metabolic circuits, enhancing glycolysis and disrupting oxidative phosphorylation, thereby promoting sustained pro-inflammatory phenotypes. Crucially, metabolic intermediates function as cofactors for epigenetic remodelling. This establishes trained immunity in both circulating innate immune cells and haematopoietic stem\/progenitor cells, which serves as the cellular basis for persistent metabolic memory. This persistent immunometabolic imprint amplifies sterile inflammation and accelerates vascular and myocardial remodelling. Furthermore, these processes are systemically propagated through cross-organ communication networks, including the heart\u2013adipose, gut\u2013heart, and cardio-hematopoietic axes, forming a multidimensional inflammatory amplification loop. We also summarise emerging therapeutic strategies targeting the metabolic\u2013epigenetic axis, aiming to reverse maladaptive trained immunity and mitigate residual CVD risk. By integrating immunometabolism, epigenetic regulation, and organ crosstalk, this review highlights metabolic reprogramming as a pivotal mechanistic nexus and potential precision target for cardiovascular protection.<\/jats:p>","DOI":"10.3390\/ijms27125526","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:37:42Z","timestamp":1781879862000},"page":"5526","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic Reprogramming-Driven Cardiovascular Immune Damage: From Glyco-Lipotoxicity and Epigenetic Memory to Multidimensional Cross-Organ Communication Networks"],"prefix":"10.3390","volume":"27","author":[{"given":"Zijin","family":"Sun","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojia","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shao","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41591-025-04169-6","article-title":"An oral, liver-restricted LXR inverse agonist for dyslipidemia: Preclinical development and phase 1 trial","volume":"32","author":"Li","year":"2026","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41401-025-01729-x","article-title":"Mechanisms, precision therapies, and technological frontiers in coronary atherosclerosis: A comprehensive review","volume":"47","author":"Qiu","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/STROKEAHA.125.052894","article-title":"Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell-Derived Extracellular Vesicles","volume":"57","author":"Kim","year":"2026","journal-title":"Stroke"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hafiane, A., and Daskalopoulou, S.S. (2022). Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis. Pharmacol. Res., 178.","DOI":"10.1016\/j.phrs.2022.106157"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/eurheartj\/ehaf196","article-title":"Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention","volume":"46","author":"Bay","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurjpc\/zwaf112","article-title":"Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular disease","volume":"33","author":"Vogel","year":"2026","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.123.066213","article-title":"CLEAR Outcomes Investigators Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13,970 Contemporary High-Risk Patients With Statin Intolerance","volume":"149","author":"Ridker","year":"2024","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/eurheartj\/ehaf658","article-title":"C-reactive protein and cardiovascular risk among women with no standard modifiable risk factors: Evaluating the \u201cSMuRF-less but inflamed\u201d","volume":"47","author":"Ridker","year":"2026","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hartley, A., Rostamian, S., Kaura, A., Chrysostomou, P., Welsh, P., Ariti, C., Sattar, N., Sever, P., and Khamis, R. (2025). The relationship of baseline high-sensitivity C-reactive protein with incident cardiovascular events and all-cause mortality over 20 years. EBioMedicine, 117.","DOI":"10.1016\/j.ebiom.2025.105786"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurjpc\/zwaf370","article-title":"High-sensitivity C-reactive protein mediates age-related vascular dysfunction: The Rotterdam study","volume":"33","author":"Claringbould","year":"2026","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Domingo, E., Marques, P., Francisco, V., Piqueras, L., and Sanz, M.-J. (2024). Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?. Pharmacol. Res., 200.","DOI":"10.1016\/j.phrs.2024.107058"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1093\/eurheartj\/ehaf281","article-title":"Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events","volume":"46","author":"Markus","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Liu, H.-H., Guo, Y.-L., Zhu, C.-G., Wu, N.-Q., Gao, Y., Xu, R.-X., Dong, Q., Qian, J., Dou, K.-F., and Li, J.-J. (2022). Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome. J. Transl. Med., 20.","DOI":"10.1186\/s12967-022-03448-x"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/eurjpc\/zwaf037","article-title":"The role of systemic inflammation in remnant cholesterol-associated cardiovascular risk: Insights from the EPIC-Norfolk study","volume":"33","author":"Kraaijenhof","year":"2026","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-023-00937-4","article-title":"Oxidized phospholipids in cardiovascular disease","volume":"21","author":"Tsimikas","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wu, D., Lan, Y., Ding, X., Balmer, L., Li, X., Wang, W., Wu, S., and Chen, Y. (2025). Imbalances in circulating monocyte and high-density lipoprotein cholesterol exacerbates the residual risk of incident myocardial infarction beyond LDL-C: A real-life, prospective cohort study. J. Transl. Med., 23, Erratum in J. Transl. Med. 2026, 24, 176. https:\/\/doi.org\/10.1186\/s12967-026-07834-7.","DOI":"10.1186\/s12967-026-07834-7"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/eurheartj\/ehad787","article-title":"Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis","volume":"45","author":"Dong","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Li, Y., Liu, Y., Wei, X., Wang, C., Zahoor Khan, M., and Ma, Q. (2026). Probiotic extracellular vesicles reprogram macrophage immunometabolism: From gut crosstalk to host health. Gut Microbes, 18.","DOI":"10.1080\/19490976.2026.2614115"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Xiang, A., Chang, A., Zhou, J., Jin, J., Zhang, X., and Wang, Q. (2025). Macrophage metabolism in inflammatory heart disease: New insights and therapeutic implications. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1664538"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ma, H., Gao, L., Chang, R., Zhai, L., and Zhao, Y. (2024). Crosstalk between macrophages and immunometabolism and their potential roles in tissue repair and regeneration. Heliyon, 10.","DOI":"10.1016\/j.heliyon.2024.e38018"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s10557-023-07466-9","article-title":"Complex Interplay Between Metabolism and CD4+ T-Cell Activation, Differentiation, and Function: A Novel Perspective for Atherosclerosis Immunotherapy","volume":"38","author":"Yang","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, J., Guo, C., Yang, X., Xie, W., Mi, W., Hua, C., Tang, C., and Wang, H. (2025). Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases. Pharmacol. Res., 213.","DOI":"10.1016\/j.phrs.2025.107634"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yang, K., Zhao, Q., Sun, Y., Lin, L., and Han, X. (2025). Mitochondrial immunometabolism in sepsis: Orchestrating macrophage polarization and dysfunction. Eur. J. Med. Res., 31.","DOI":"10.1186\/s40001-025-03590-4"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41584-025-01267-0","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"21","author":"Kaplan","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sarandi, E., Krueger-Krasagakis, S., Tsoukalas, D., Sidiropoulou, P., Evangelou, G., Sifaki, M., Rudofsky, G., Drakoulis, N., and Tsatsakis, A. (2023). Psoriasis immunometabolism: Progress on metabolic biomarkers and targeted therapy. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1201912"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"C558","DOI":"10.1152\/ajpcell.00276.2022","article-title":"Glycolytic side pathways regulating macrophage inflammatory phenotypes and functions","volume":"324","author":"Tomas","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s42255-021-00440-5","article-title":"SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation","volume":"3","author":"Bidault","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Liao, D.-H., Jiang, S.-L., Wu, T., Cao, Z., Zhu, Z.-W., Wu, N., Zhang, X., Long, M.-H., Wang, J., and Wang, Z.-B. (2026). TRP channels at the crossroads of metabolism and immunity: Ion-metabolite coupling in inflammation and disease. Metabolism, 176.","DOI":"10.1016\/j.metabol.2025.156486"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kunz, N., and Kemper, C. (2021). Complement Has Brains-Do Intracellular Complement and Immunometabolism Cooperate in Tissue Homeostasis and Behavior?. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.629986"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"C456","DOI":"10.1152\/ajpcell.00153.2025","article-title":"Metabolic dysregulation of trained immunity in immune aging and the impact of dietary patterns","volume":"329","author":"Grigorescu","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Riksen, N.P., and Netea, M.G. (2021). Immunometabolic control of trained immunity. Mol. Asp. Med., 77.","DOI":"10.1016\/j.mam.2020.100897"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41569-025-01165-8","article-title":"Immunometabolism in heart failure","volume":"22","author":"Andreadou","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s44161-024-00473-5","article-title":"Immunometabolism in atherosclerotic disorders","volume":"3","author":"Fleetwood","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10557-024-07545-5","article-title":"Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases","volume":"39","author":"Hang","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.tibs.2024.06.003","article-title":"Immunometabolism in atherosclerosis: A new understanding of an old disease","volume":"49","author":"Certo","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Boden, K.A., Chai, J., Kufazvinei, T.T.J., and Choudhury, R.P. (2026). Trained Immunity and Cardiovascular Risk: An Immunological Perspective. Immunol. Rev., 337.","DOI":"10.1111\/imr.70095"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/eurheartj\/ehaf982","article-title":"Trained immunity in cardiovascular disease","volume":"47","author":"Riksen","year":"2026","journal-title":"Eur. Heart J."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yao, M., Zhou, J., Mei, J., Gao, C., Ding, P., Li, G., Zhang, C., Li, Z., and Gao, J. (2025). Trained Immunity in Health and Disease. MedComm, 6.","DOI":"10.1002\/mco2.70461"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1152\/physrev.00031.2021","article-title":"Trained immunity: Adaptation within innate immune mechanisms","volume":"103","author":"Bekkering","year":"2023","journal-title":"Physiol. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41422-025-01171-y","article-title":"Trained immunity: Induction of an inflammatory memory in disease","volume":"35","author":"Priem","year":"2025","journal-title":"Cell Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-102119-073855","article-title":"Trained Immunity: Reprogramming Innate Immunity in Health and Disease","volume":"39","author":"Bekkering","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41569-023-00894-y","article-title":"Trained immunity in atherosclerotic cardiovascular disease","volume":"20","author":"Riksen","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.molcel.2025.05.014","article-title":"No (innate immune) training without lactate","volume":"85","year":"2025","journal-title":"Mol. Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.it.2025.05.002","article-title":"Lactate trains immunity","volume":"46","author":"Llibre","year":"2025","journal-title":"Trends Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cytogfr.2026.01.003","article-title":"Reprogramming immunity at the metabolic-epidermal interface in obesity-associated psoriasis","volume":"88","author":"Jang","year":"2026","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2337\/dc24-2885","article-title":"The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study","volume":"48","author":"Braffett","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Prattichizzo, F., de Candia, P., and Ceriello, A. (2021). Diabetes and kidney disease: Emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists. Metabolism, 120.","DOI":"10.1016\/j.metabol.2021.154799"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00125-021-05397-4","article-title":"Realising the long-term promise of insulin therapy: The DCCT\/EDIC study","volume":"64","author":"Nathan","year":"2021","journal-title":"Diabetologia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","article-title":"Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis","volume":"144","author":"Edgar","year":"2021","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","article-title":"Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities","volume":"185","author":"Li","year":"2022","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev-physiol-052521-013627","article-title":"Inflammatory Modulation of Hematopoiesis: Linking Trained Immunity and Clonal Hematopoiesis with Chronic Disorders","volume":"84","author":"Chavakis","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/s12276-025-01542-w","article-title":"Trained immunity induced by DAMPs and LAMPs in chronic inflammatory diseases","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/cvr\/cvad003","article-title":"Bone marrow inflammatory memory in cardiometabolic disease and inflammatory comorbidities","volume":"119","author":"Mitroulis","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/prd.12421","article-title":"Maladaptive trained immunity and clonal hematopoiesis as potential mechanistic links between periodontitis and inflammatory comorbidities","volume":"89","author":"Hajishengallis","year":"2022","journal-title":"Periodontol. 2000"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Chen, H., Wei, L., Yu, Q., Wang, C., Fan, H., Li, M., Dong, R., Ma, Y., Jiang, J., and Deng, L. (2026). Injectable hydrogels for osteomyelitis treatment induce metabolic reprogramming for protection against reinfection. Nat. Commun., 17.","DOI":"10.1038\/s41467-026-68318-2"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Priem, B., Willemsen, L., Anbergen, T., van Elsas, Y., Deckers, J., Schrijver, D.P., Hofstraat, S.R.J., Messing, I.V., Munitz, J., and Honing, D. (2026). Systemically inducing trained immunity overcomes solid tumors\u2019 immunosuppressive microenvironment. Sci. Adv., 12.","DOI":"10.1126\/sciadv.adu0292"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Bhattarai, S., Li, Q., Ding, J., Liang, F., Gusev, E., Lapohos, O., Fonseca, G.J., Kaufmann, E., Divangahi, M., and Petrof, B.J. (2022). TLR4 is a regulator of trained immunity in a murine model of Duchenne muscular dystrophy. Nat. Commun., 13.","DOI":"10.1038\/s41467-022-28531-1"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Yu, Z., Chen, Z., Xie, H., Duan, P., Hu, H., Zhang, H., Ye, X., Yu, Y., Cheng, Y., and Pan, Z. (2025). A metabolic reprogramming and trained immunity hydrogel mimic cluster missiles to eliminate infection and treat infected diabetic wounds. J. Nanobiotechnol., 23.","DOI":"10.1186\/s12951-025-03818-9"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Castelo, J., Araujo-Aris, S., Barriales, D., Tanner Pasco, S., Seoane, I., Pe\u00f1a-Cearra, A., Palacios, A., Sim\u00f3, C., Garcia-Ca\u00f1as, V., and Khamwong, M. (2024). The microbiota metabolite, phloroglucinol, confers long-term protection against inflammation. Gut Microbes, 16.","DOI":"10.1080\/19490976.2024.2438829"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCRESAHA.124.323778","article-title":"Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential","volume":"136","author":"Kohutek","year":"2025","journal-title":"Circ. Res."},{"key":"ref_61","unstructured":"(2026, April 18). Activated ATF6\u03b1 is a Hepatic Tumour Driver Restricting Immunosurveillance\u2014PubMed[EB\/OL], Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/41639449\/."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"69180","DOI":"10.1021\/acsami.5c19664","article-title":"Mitochondrial-Targeting Drug-Loaded Nanoparticles Reprogram Macrophage Metabolism via ROS\/NO Co-elimination for Diabetic Wound Healing","volume":"17","author":"Zhou","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Nogales, P., Velasco, C., Gonz\u00e1lez-Cintado, L., Sharysh, D., Mota-Cobi\u00e1n, A., Izquierdo-Serrano, R., Torroja, C., Del Rio-Aledo, D., Morales-Cano, D., and Mota, R.A. (2025). Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET. Sci. Transl. Med., 17.","DOI":"10.1126\/scitranslmed.ado6467"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bertschi, N.L., Steck, O., Luther, F., Bazzini, C., von Meyenn, L., Sch\u00e4rli, S., Vallone, A., Felser, A., Keller, I., and Friedli, O. (2023). PPAR-\u03b3 regulates the effector function of human T helper 9 cells by promoting glycolysis. Nat. Commun., 14.","DOI":"10.1038\/s41467-023-38233-x"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Cheng, G., Liu, Y., Xing, Y., Shi, Z., Farag, M.A., Jin, S., and Xia, B. (J. Adv. Res., 2026). Lactylation at the metabolic-epigenetic interface in cardiovascular diseases: Context-dependent mechanisms and translational roadmap, J. Adv. Res., in press.","DOI":"10.1016\/j.jare.2026.01.007"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Zhou, H., Xiao, Y., Xue, X., Liu, J., Xu, H., Wang, J., Zhou, J., Zuo, Q., Liang, W., and Song, H. (2025). Hyperglycemia exacerbates osteoarthritis by impairing macrophage efferocytosis through modulation of CD11b lactylation. Nat. Commun., 17.","DOI":"10.1038\/s41467-025-67473-2"},{"key":"ref_67","first-page":"152","article-title":"Bidirectional modulation of glycolysis using a multifunctional nanocomposite hydrogel promotes bone fracture healing in type 2 diabetes mellitus","volume":"50","author":"Zhang","year":"2025","journal-title":"Bioact. Mater."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Sun, K., Chen, Y., Zheng, S., Wan, W., and Hu, K. (2024). Genipin ameliorates diabetic retinopathy via the HIF-1\u03b1 and AGEs-RAGE pathways. Phytomedicine, 129.","DOI":"10.1016\/j.phymed.2024.155596"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Song, C., Hu, P., Peng, R., Li, F., Fang, Z., and Xu, Y. (2024). Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration. Pharmacol. Res., 202.","DOI":"10.1016\/j.phrs.2024.107119"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Issad, T., Al-Mukh, H., Bouaboud, A., and Pagesy, P. (2022). Protein O-GlcNAcylation and the regulation of energy homeostasis: Lessons from knock-out mouse models. J. Biomed. Sci., 29.","DOI":"10.1186\/s12929-022-00851-w"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lei, Y., Liu, Q., Chen, B., Wu, F., Li, Y., Dong, X., Ma, N., Wu, Z., Zhu, Y., and Wang, L. (2024). Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy. Nat. Commun., 15.","DOI":"10.1038\/s41467-024-53601-x"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Qi, B., Chai, S., Chen, Y., Zhou, G., Li, P., Li, X., Lu, X., and Huang, L.-H. (2025). O-linked \u03b2-N-acetylglucosamine modification in diabetic foot ulcer pathogenesis. Burn. Trauma., 13.","DOI":"10.1093\/burnst\/tkaf044"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2021.05.022","article-title":"Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seeding","volume":"517","author":"Alsheikh","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Martati, E., Wang, H., Rietjens, I.M.C.M., and Zheng, L. (2026). Advanced glycation end products (AGEs) and in vitro and in vivo approaches to study their mechanisms of action and the protective properties of natural compounds. Phytomedicine, 150.","DOI":"10.1016\/j.phymed.2026.157772"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","article-title":"AGE\/RAGE in diabetic kidney disease and ageing kidney","volume":"171","author":"Wu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Meng, Y., Hou, Y., Zhang, R., Guo, Z., Zhang, Z., Li, J., Yan, Y., Chang, Y., Li, D., and Chang, L. (2026). Jinlida ameliorates diabetic kidney disease via gut microbiota-dependent production of pyridoxamine targeting renal AGEs\/RAGE and TGF-\u03b2 pathways. Phytomedicine, 150.","DOI":"10.1016\/j.phymed.2025.157744"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Zhu, D., Ni, Y., Chen, C., Dong, Z., Wang, L., and Zhang, W. (2024). Geniposide ameliorates diabetic nephropathy in type 2 diabetic mice by targeting AGEs-RAGE-dependent inflammatory pathway. Phytomedicine, 135.","DOI":"10.1016\/j.phymed.2024.156046"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Tang, Z., Xu, N., Lyu, P., Zhao, H., and Zheng, W. (2025). Cross-talk between cancer and diabetes: Exploring shared molecular pathways in cellular metabolism and signaling. Mol. Asp. Med., 106.","DOI":"10.1016\/j.mam.2025.101420"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Zheng, X., Xie, L., Xu, H., Chen, J., Xing, H., Yin, Y., Gao, J., Zhang, S., and Fang, F. (2025). Integrated metabolomics and network pharmacology analysis of Yulan Jiangtang capsules in diabetic nephropathy. Phytomedicine, 147.","DOI":"10.1016\/j.phymed.2025.157189"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"22668","DOI":"10.1021\/acsnano.3c06999","article-title":"Tetrahedral Framework Nucleic Acids Based Small Interfering RNA Targeting Receptor for Advanced Glycation End Products for Diabetic Complications Treatment","volume":"17","author":"Cai","year":"2023","journal-title":"ACS Nano"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Meng, B., Li, Y., Ding, Y., Xu, X., Wang, L., Guo, B., Zhu, B., Zhang, J., Xiang, L., and Dong, J. (2021). Myeloid-derived growth factor inhibits inflammation and alleviates endothelial injury and atherosclerosis in mice. Sci. Adv., 7, Erratum in Sci. Adv. 2026, 12, eaeg3540. https:\/\/doi.org\/10.1126\/sciadv.aeg3540.","DOI":"10.1126\/sciadv.abe6903"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCRESAHA.125.326839","article-title":"TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in Atherosclerosis","volume":"137","author":"Singhal","year":"2025","journal-title":"Circ. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.7150\/thno.124140","article-title":"Impairment of mitochondrial quality control exacerbates diabetes-related atrial fibrillation by cGAS-STING signaling pathway and cardiomyocyte-macrophage crosstalk","volume":"16","author":"Meng","year":"2026","journal-title":"Theranostics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2025.04.070","article-title":"Plaque Vulnerability and Cardiovascular Risk Factor Burden in Acute Coronary Syndrome: An Optical Coherence Tomography Analysis","volume":"86","author":"Covani","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41569-024-01100-3","article-title":"Cholesterol crystals in the pathogenesis of atherosclerosis","volume":"22","author":"Baumer","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Niyonzima, N., Rahman, J., Kunz, N., West, E.E., Freiwald, T., Desai, J.V., Merle, N.S., Gidon, A., Sporsheim, B., and Lionakis, M.S. (2021). Mitochondrial C5aR1 activity in macrophages controls IL-1\u03b2 production underlying sterile inflammation. Sci. Immunol., 6.","DOI":"10.1126\/sciimmunol.abf2489"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/cvr\/cvaf159","article-title":"Oxidized LDL-induced FOXS1 mediates cholesterol transport dysfunction and inflammasome activation to drive aortic valve calcification","volume":"121","author":"Jiang","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"He, X., Fan, X., Bai, B., Lu, N., Zhang, S., and Zhang, L. (2021). Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis. Pharmacol. Res., 165.","DOI":"10.1016\/j.phrs.2021.105447"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Luo, Y., Guo, Y., Wang, H., Yu, M., Hong, K., Li, D., Li, R., Wen, B., Hu, D., and Chang, L. (2021). Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation. EBioMedicine, 74.","DOI":"10.1016\/j.ebiom.2021.103725"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Jalil, A., Pilot, T., Bourgeois, T., Laubriet, A., Li, X., Diedisheim, M., Deckert, V., Magnani, C., Le Guern, N., and Pais de Barros, J.-P. (2025). Plasmalogen remodeling modulates macrophage response to cytotoxic oxysterols and atherosclerotic plaque vulnerability. Cell Rep. Med., 6.","DOI":"10.1016\/j.xcrm.2025.102131"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/eurheartj\/ehaa770","article-title":"Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): A crucial driver of atherosclerotic cardiovascular disease","volume":"42","author":"Akhmedov","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ben Dhaou, C., Al-Yafeai, Z., Cruz-Marquez, G.A., Scott, M.L., Pearson-Gallion, B., Cockerham, E., Li, H., Peretik, J.M., Hong, Y., and Dhanesha, N. (2025). Integrin-specific signaling drives ER stress-dependent atherogenic endothelial activation. Redox Biol., 88.","DOI":"10.1016\/j.redox.2025.103911"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/cvr\/cvae223","article-title":"Mechanisms and consequences of myeloid adhesome dysfunction in atherogenesis","volume":"121","author":"Zhevlakova","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Hsu, Y.-W., Hsu, F.-F., Chiang, M.-T., Tsai, D.-L., Li, F.-A., Angata, T., Crocker, P.R., and Chau, L.-Y. (2021). Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation. J. Biomed. Sci., 28.","DOI":"10.1186\/s12929-020-00698-z"},{"key":"ref_95","first-page":"252","article-title":"Extracellular vesicles from IPFP-MSCs trigger osteoarthritis by transferring mtDNA","volume":"58","author":"Li","year":"2026","journal-title":"Bioact. Mater."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"31569","DOI":"10.1021\/acsnano.4c13262","article-title":"Unveiling the Heart\u2019s Hidden Enemy: Dynamic Insights into Polystyrene Nanoplastic-Induced Cardiotoxicity Based on Cardiac Organoid-on-a-Chip","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cho, S., Sung, H.K., Nguyen, K., Lei, Y., Wannaiampikul, S., Lee, B., Tam, E., Luo, Y., Petrotchenko, E.V., and Borchers, C.H. (2026). Lipidomic Analysis of Plasma Extracellular Vesicles from Adiponectin Deficient Mice or Metabolic Syndrome Patients Reveals Pro-Oxidative and Pro-Inflammatory Lipid Signatures Correlating with Metabolic Dysfunction. J. Extracell. Vesicles, 15.","DOI":"10.1002\/jev2.70229"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1016\/j.apsb.2025.06.014","article-title":"Targeted inhibition of macrophage STING signaling alleviates inflammatory injury and ventricular remodeling in acute myocardial infarction","volume":"15","author":"Yao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Yan, L., Hu, X., He, J., Gan, H., Shi, Y., Li, L., Li, S., Wei, K., Wei, J., and Cai, J. (2025). Folate-modified biomimetic nanovesicles loaded with a PU.1 inhibitor alleviate atherosclerosis by suppressing inflammation. J. Nanobiotechnol., 24.","DOI":"10.1186\/s12951-025-03825-w"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Li, C., Zhang, Z., Luo, C., Lan, W., Liu, C., Liu, W., Xiang, H., Yang, J., Tang, Y., and Wang, X. (2025). A mitochondria-targeted nanomedicine for myocardial ischemia\/reperfusion injury with synergistic antioxidant and anti-inflammatory properties. J. Nanobiotechnol., 23.","DOI":"10.1186\/s12951-025-03810-3"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Duan, J., Cao, Z., Zhou, Z., Huang, X., Zhao, J., Huang, Y., Huang, T., Meng, S., Chen, X., and Hong, T. (J. Adv. Res., 2025). Mitochondrial dysfunction drives ZBP1-mediated PANoptosis to increase the susceptibility of heart failure with preserved ejection fraction-associated atrial fibrillation, J. Adv. Res., in press.","DOI":"10.1016\/j.jare.2025.09.016"},{"key":"ref_102","first-page":"23","article-title":"Biomimetic dynamic nanomedicine SrHCF: Lattice self-reconstruction based on Fe2+ response to achieve synergistic \u201cferrous chelation-antioxidation-calcium antagonism-inflammation inhibition\u201d quadruple treatment of CIRI","volume":"55","author":"Xiong","year":"2026","journal-title":"Bioact. Mater."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Hu, D., Lin, Y., Huang, H., Xian, G., Chen, Y., Li, J., Huang, L., Xu, M., Lin, X., and Wen, L. (2026). CircZBTB44-Encoded Peptide ZBTB44-342aa Alleviates Aortic Valve Calcification via cGAS-STING Inhibition. Circ. Res., 138.","DOI":"10.1161\/CIRCRESAHA.125.326771"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/cvr\/cvaf232","article-title":"Targeting olfactory receptor 2 on monocytes for cardioprotection against myocardial ischaemia-reperfusion injury via NR4A1-mediated mitochondrial fission","volume":"121","author":"Zhang","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCRESAHA.123.324138","article-title":"Ferroptosis-Mediated Inflammation Promotes Pulmonary Hypertension","volume":"135","author":"Kazmirczak","year":"2024","journal-title":"Circ. Res."},{"key":"ref_106","first-page":"908","article-title":"Polydopamine as a biocompatible and precise mitochondrial targeted therapeutic platform for reversing myocardial ischemia-reperfusion injury","volume":"53","author":"Zhao","year":"2025","journal-title":"Bioact. Mater."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Seldeslachts, L., Kraisin, S., Dewi, I.M.W., Feys, S., Staels, F., Gkountzinopoulou, M., Jacobs, C., Tielemans, B., Vanhoffelen, E., and Res\u00e9ndiz-Sharpe, A. (2025). Anakinra restores immunological misfiring that drives influenza-associated pulmonary aspergillosis. Sci. Transl. Med., 17.","DOI":"10.1126\/scitranslmed.adw9578"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/cvr\/cvaf248","article-title":"Myeloperoxidase aggravates thoracic aortic aneurysm formation in Marfan disease","volume":"122","author":"Mehrkens","year":"2026","journal-title":"Cardiovasc. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/cvr\/cvaf173","article-title":"Iron regulatory proteins secure iron availability in skeletal muscle to preserve exercise tolerance in heart failure","volume":"121","author":"Chung","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/all.16461","article-title":"BLOC1S1 Control of Vacuolar Organelle Fidelity Modulates Murine TH2 Cell Immunity and Allergy Susceptibility","volume":"80","author":"Sharma","year":"2025","journal-title":"Allergy"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Okuma, H., and Tsuchiya, K. (2024). Tissue-specific activation of insulin signaling as a potential target for obesity-related metabolic disorders. Pharmacol. Ther., 262.","DOI":"10.1016\/j.pharmthera.2024.108699"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvae193","article-title":"Insulin receptors in vascular smooth muscle cells regulate plaque stability of atherosclerosis","volume":"120","author":"Li","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_113","unstructured":"(2026, April 18). Integrated Multi-Omic Characterization of Congenital Heart Disease\u2014PubMed[EB\/OL], Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/35732239\/."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCRESAHA.121.319582","article-title":"Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis","volume":"131","author":"Park","year":"2022","journal-title":"Circ. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2025.11.009","article-title":"Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade","volume":"38","author":"Wu","year":"2026","journal-title":"Cell Metab."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cvr\/cvag036","article-title":"HIV-pharmacotherapy and pathogenesis of diabetes-induced cardiovascular complications: An updated narrative review","volume":"122","author":"Maswanganyi","year":"2026","journal-title":"Cardiovasc. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcancer.2025.09.007","article-title":"Lipid-laden macrophages in atherosclerosis and cancer","volume":"117","author":"Han","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Rui, H., Yu, H., Chi, K., Han, Z., Zhu, W., Zhang, J., Guo, H., Zou, W., Wang, F., and Xu, P. (2024). ALDH2 deficiency augments atherosclerosis through the USP14-cGAS-dependent polarization of proinflammatory macrophages. Redox Biol., 76.","DOI":"10.1016\/j.redox.2024.103318"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.7150\/thno.94738","article-title":"Methyl-CpG-binding 2 K271 lactylation-mediated M2 macrophage polarization inhibits atherosclerosis","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/cvr\/cvab027","article-title":"Kr\u00fcppel-like factor 14 deletion in myeloid cells accelerates atherosclerotic lesion development","volume":"118","author":"Wang","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCULATIONAHA.125.076514","article-title":"Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Formation by Targeting LOX-1","volume":"153","author":"Zhang","year":"2026","journal-title":"Circulation"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhang, X., Yu, L., Cao, L., Zhang, J., Li, Q., Wang, X., Qi, W., Cai, L., and Ren, R. (2025). E3 ubiquitin ligase RNF128 promotes Lys63-linked polyubiquitination on SRB1 in macrophages and aggravates atherosclerosis. Nat. Commun., 16.","DOI":"10.1038\/s41467-025-57404-6"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Boccuni, L., Marka, F., Salzmann, M., Schirripa, A., Ableitner, E., Siller, M., Brekalo, M., Haider, P., Stojkovic, S., and Neumayer, C. (2025). Mitochondrial ROS drive foam cell formation via STAT5 signaling in atherosclerosis. Sci. Adv., 11.","DOI":"10.1126\/sciadv.adw9952"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jare.2024.11.016","article-title":"Kaempferol regulating macrophage foaming and atherosclerosis through Piezo1-mediated MAPK\/NF-\u03baB and Nrf2\/HO-1 signaling pathway","volume":"75","author":"Chu","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41569-024-01072-4","article-title":"Lysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis","volume":"22","author":"Bonacina","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1093\/eurheartj\/ehaf241","article-title":"Nuclear receptor Dax1 promotes atherosclerosis by lipid transport inhibition and autophagy suppression in macrophages","volume":"46","author":"Li","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jare.2023.11.004","article-title":"ASIC1\/RIP1 accelerates atherosclerosis via disrupting lipophagy","volume":"63","author":"Wang","year":"2024","journal-title":"J. Adv. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1080\/15548627.2021.1909833","article-title":"Augmenting ATG14 alleviates atherosclerosis and inhibits inflammation via promotion of autophagosome-lysosome fusion in macrophages","volume":"17","author":"Zhang","year":"2021","journal-title":"Autophagy"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Zhao, J., Hu, B., Xiao, H., Yang, Q., Cao, Q., Li, X., Zhang, Q., Ji, A., and Song, S. (2021). Fucoidan reduces lipid accumulation by promoting foam cell autophagy via TFEB. Carbohydr. Polym., 268.","DOI":"10.1016\/j.carbpol.2021.118247"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1080\/15548627.2020.1822088","article-title":"Vitamin D3-VDR-PTPN6 axis mediated autophagy contributes to the inhibition of macrophage foam cell formation","volume":"17","author":"Kumar","year":"2021","journal-title":"Autophagy"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1080\/15548627.2021.1886839","article-title":"Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells","volume":"17","author":"Robichaud","year":"2021","journal-title":"Autophagy"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1089\/ars.2021.0116","article-title":"Oxidative Stress in Neutrophils: Implications for Diabetic Cardiovascular Complications","volume":"36","author":"Johnson","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Zhu, W., Guo, S., Homilius, M., Nsubuga, C., Wright, S.H., Quan, D., Kc, A., Eddy, S.S., Victorio, R.A., and Beerens, M. (2022). PIEZO1 mediates a mechanothrombotic pathway in diabetes. Sci. Transl. Med., 14.","DOI":"10.1126\/scitranslmed.abk1707"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Joshi, M.B., Ahamed, R., Hegde, M., Nair, A.S., Ramachandra, L., and Satyamoorthy, K. (2020). Glucose induces metabolic reprogramming in neutrophils during type 2 diabetes to form constitutive extracellular traps and decreased responsiveness to lipopolysaccharides. Biochim. Biophys. Acta Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165940"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Hamam, H.J., and Palaniyar, N. (2019). Post-Translational Modifications in NETosis and NETs-Mediated Diseases. Biomolecules, 9.","DOI":"10.3390\/biom9080369"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Juanlu, C., Chen, L., Sung, C.-J., and Hsieh, S.-C. (2026). Phytochemicals as potential inhibitors of NETosis: Implications for immunothrombosis and chronic disease management. BMC Complement. Med. Ther., 26.","DOI":"10.1186\/s12906-025-05233-x"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Shirakawa, K., and Sano, M. (2022). Neutrophils and Neutrophil Extracellular Traps in Cardiovascular Disease: An Overview and Potential Therapeutic Approaches. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081850"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Gauer, J.S., Ajjan, R.A., and Ari\u00ebns, R.A.S. (2022). Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches. J. Am. Heart Assoc., 11.","DOI":"10.1161\/JAHA.122.027071"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cvr\/cvad017","article-title":"Fibrin clot properties in cardiovascular disease: From basic mechanisms to clinical practice","volume":"119","author":"Undas","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Bryk-Wi\u0105zania, A.H., and Undas, A. (2021). Hypofibrinolysis in type 2 diabetes and its clinical implications: From mechanisms to pharmacological modulation. Cardiovasc. Diabetol., 20.","DOI":"10.1186\/s12933-021-01372-w"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Baratta, F., Bartimoccia, S., Pastori, D., Cocomello, N., Cammisotto, V., Castellani, V., Nocella, C., Forte, M., Picchio, V., and Carnevale, R. (2025). Neutrophil cathepsin G and risk of cardiovascular events in patients with diabetes mellitus. Cardiovasc. Diabetol., 24.","DOI":"10.1186\/s12933-025-03005-y"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Schommer, N., Gendron, N., Krauel, K., Van Bruggen, S., Jarrot, P.-A., Maier, A., Chan, W., Langer, H.F., Duerschmied, D., and Westermann, D. (2025). Neutrophil extracellular traps and peptidylarginine deiminase 4-mediated inflammasome activation link diabetes to cardiorenal injury and heart failure. Eur. Heart J.","DOI":"10.1093\/eurheartj\/ehaf963"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/STROKEAHA.123.042714","article-title":"Targeting Neutrophil \u03b19 Improves Functional Outcomes After Stroke in Mice With Obesity-Induced Hyperglycemia","volume":"54","author":"Patel","year":"2023","journal-title":"Stroke"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Aukrust, S.G., Holte, K.B., Opstad, T.B., Seljeflot, I., Berg, T.J., and Helseth, R. (2021). NETosis in Long-Term Type 1 Diabetes Mellitus and Its Link to Coronary Artery Disease. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.799539"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Sui, D., Liu, F., Zheng, L., Yu, S., Ding, Z., Ren, X., Gao, J., Wang, W., and Yang, L. (2026). Disease-associated neutrophil heterogeneity in cancer therapy: Implications for precision immunotherapy. Crit. Rev. Oncol. Hematol., 220.","DOI":"10.1016\/j.critrevonc.2026.105182"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Shafqat, A., Abdul Rab, S., Ammar, O., Al Salameh, S., Alkhudairi, A., Kashir, J., Alkattan, K., and Yaqinuddin, A. (2022). Emerging role of neutrophil extracellular traps in the complications of diabetes mellitus. Front. Med., 9.","DOI":"10.3389\/fmed.2022.995993"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cvr\/cvad029","article-title":"Inhibition of phosphoglycerate kinase 1 attenuates autoimmune myocarditis by reprogramming CD4+ T cell metabolism","volume":"119","author":"Lu","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Wang, Q., Wang, Y., Lin, Y., Zhou, J., Mao, Z., Gu, X., Chen, H., Li, J., Chen, A., and Zhang, J. (2025). Thymic Bmi-1 hampers \u03b3\u03b4T17 generation and its derived ROR\u03b3t-IL-17A signaling to delay cardiac aging. Proc. Natl. Acad. Sci. USA, 122.","DOI":"10.1073\/pnas.2414717122"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Sun, P., Zhang, Z., Gao, F., Yang, C., Mang, G., Fu, S., Tian, J., and Chang, J. (2025). Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling. Sci. Adv., 11.","DOI":"10.1126\/sciadv.adr7208"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s44161-025-00671-9","article-title":"Loss of effector Treg signature in APOB-reactive CD4+ T cells in patients with coronary artery disease","volume":"4","author":"Roy","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/joim.13434","article-title":"Liver damage promotes pro-inflammatory T-cell responses against apolipoprotein B-100","volume":"291","author":"Plochg","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","article-title":"Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism","volume":"43","author":"Haghikia","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.7150\/thno.68437","article-title":"CD4+FoxP3+CD73+ regulatory T cell promotes cardiac healing post-myocardial infarction","volume":"12","author":"Zhuang","year":"2022","journal-title":"Theranostics"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Soussi, S., Maione, A.S., Lef\u00e8vre, L., Pizzinat, N., Iacovoni, J., Gonzalez-Fuentes, I., Cussac, D., Iengo, L., Santin, Y., and Tundo, F. (2025). Analysis of effector\/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis. Cell Death Dis., 16.","DOI":"10.1038\/s41419-025-07364-y"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41569-021-00582-9","article-title":"Effects of fatty acids on T cell function: Role in atherosclerosis","volume":"18","author":"Reilly","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Bazioti, V., La Rose, A.M., Maassen, S., Bianchi, F., de Boer, R., Halmos, B., Dabral, D., Guilbaud, E., Flohr-Svendsen, A., and Groenen, A.G. (2022). T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice. Nat. Commun., 13.","DOI":"10.1038\/s41467-022-31135-4"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Wu, H., Zhao, X., Hochrein, S.M., Eckstein, M., Gubert, G.F., Kn\u00f6pper, K., Mansilla, A.M., \u00d6ner, A., Doucet-Ladev\u00e8ze, R., and Schmitz, W. (2023). Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming. Nat. Commun., 14.","DOI":"10.1038\/s41467-023-42634-3"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s44161-025-00713-2","article-title":"Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis","volume":"4","author":"Mulholland","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"O\u2019Quinn, K.R., Wright, C.B., Khan, M., Spitz, R.W., Rouhi, N., Morato, J.G., Vidal, P.A., Omoto, A.C.M., da Silva, A.A., and do Carmo, J.M. (2026). Distinct immunometabolic signatures of type 1 versus type 2 diabetes in a murine model of myocardial infarction. Cardiovasc. Diabetol., 25.","DOI":"10.1186\/s12933-026-03099-y"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s44161-024-00507-y","article-title":"Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction","volume":"3","author":"Bayer","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.125.073836","article-title":"Single-Cell Multi-Omics Identifies Specialized Cytotoxic and Migratory CD8+ Effector T Cells in Acute Myocarditis","volume":"152","author":"Tong","year":"2025","journal-title":"Circulation"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s44161-023-00356-1","article-title":"Human circulating CD24hi marginal zone B cells produce IgM targeting atherogenic antigens and confer protection from vascular disease","volume":"2","author":"Pattarabanjird","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cvr\/cvae027","article-title":"Marginal zone B cells produce \u201cnatural\u201d atheroprotective IgM antibodies in a T cell-dependent manner","volume":"120","author":"Harrison","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCRESAHA.121.320436","article-title":"B-1b Cells Possess Unique bHLH-Driven P62-Dependent Self-Renewal and Atheroprotection","volume":"130","author":"Pattarabanjird","year":"2022","journal-title":"Circ. Res."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Martos-Folgado, I., Del Monte-Monge, A., Lorenzo, C., Busse, C.E., Delgado, P., Mur, S.M., Cobos-Figueroa, L., Escol\u00e0-Gil, J.C., Mart\u00edn-Ventura, J.L., and Wardemann, H. (2022). MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses. Cell Rep., 41.","DOI":"10.1016\/j.celrep.2022.111468"},{"key":"ref_167","first-page":"2544","article-title":"Humoral immunity in atherosclerosis and myocardial infarction: From B cells to antibodies","volume":"117","author":"Porsch","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Mohanta, S.K., Hong, M., Deng, X., Dou, X., Xu, X., Monjezi, M., Li, Y., Sun, T., Wang, Z., and Habenicht, A.J.R. (2026). Artery Tertiary Lymphoid Organs Form Neuroimmune Cardiovascular Interfaces in Atherosclerosis. Immunol. Rev., 337.","DOI":"10.1111\/imr.70106"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Wang, R., Tan, X.W., Yu, C., Li, M., Wang, S., Yuan, B., Ma, X., Liu, Q., Matsuura, E., and Shen, L. (2026). The regulatory roles of Beta-2 glycoprotein I (\u03b22GPI) in thrombosis and hemostasis and abnormal disease conditions developed by autoantibodies against \u03b22GPI. Autoimmun. Rev., 25.","DOI":"10.1016\/j.autrev.2025.103984"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurheartj\/ehaa995","article-title":"Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms","volume":"42","author":"Kyaw","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2337\/dc20-2089","article-title":"Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes","volume":"44","author":"Sveen","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2026.01.003","article-title":"Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease","volume":"119","author":"Rotllan","year":"2026","journal-title":"Semin. Cancer Biol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"W\u0101ng, Y., Wang, C., Jiang, Y., Wang, T., Wu, T., and Tang, M. (2025). Carbonaceous cores serve as surrogates for environmental particulate matter inducing vascular endothelial inflammation via inflammasome activation. J. Hazard. Mater., 486.","DOI":"10.1016\/j.jhazmat.2024.137011"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/s12276-025-01552-8","article-title":"S100A8\/9-NLRP3-mediated chronic unresolved inflammation drives cardiac pathologies following invasive pneumococcal disease","volume":"57","author":"Tousif","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"8587","DOI":"10.7150\/thno.118369","article-title":"Single-cell RNA sequencing reveals that myeloid S100A8\/A9 is a novel regulator of the transition from adaptive hypertrophy to heart failure after pressure overload","volume":"15","author":"Yu","year":"2025","journal-title":"Theranostics"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41418-025-01489-5","article-title":"Macrophage junctional adhesion molecule-like (JAML) protein promotes NLRP3 inflammasome activation in the development of atherosclerosis","volume":"32","author":"Cui","year":"2025","journal-title":"Cell Death Differ."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCRESAHA.124.325196","article-title":"LncRNA MIR181A1HG Deficiency Attenuates Vascular Inflammation and Atherosclerosis","volume":"136","author":"Ni","year":"2025","journal-title":"Circ. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cvr\/cvae071","article-title":"Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis","volume":"120","author":"Guo","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Liu, D., Ye, Y., Lan, Z., Chen, A., Zhou, X., Li, Z., Wen, X., Xiao, J., Ouyang, F., and Yan, J. (2026). Ultrasmall Cu2-xSe nanoparticles alleviate vascular calcification through inhibiting oxidative stress and NF-\u03baB\/NLRP3-mediated inflammation. Redox Biol., 89.","DOI":"10.1016\/j.redox.2025.103961"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.124.069574","article-title":"METTL4-Mediated Mitochondrial DNA N6-Methyldeoxyadenosine Promoting Macrophage Inflammation and Atherosclerosis","volume":"151","author":"Zheng","year":"2025","journal-title":"Circulation"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCRESAHA.122.322227","article-title":"ZBP1 Protects Against mtDNA-Induced Myocardial Inflammation in Failing Hearts","volume":"132","author":"Enzan","year":"2023","journal-title":"Circ. Res."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Baik, S.H., Ramanujan, V.K., Becker, C., Fett, S., Underhill, D.M., and Wolf, A.J. (2023). Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation. Sci. Immunol., 8.","DOI":"10.1126\/sciimmunol.ade7652"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.abg3067","article-title":"Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production","volume":"375","author":"Orecchioni","year":"2022","journal-title":"Science"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.7150\/thno.122995","article-title":"Mechanosensitive snoRNA-like circular RNA sno-circCNOT1 drives endothelial dysfunction and atherosclerosis","volume":"16","author":"Bi","year":"2026","journal-title":"Theranostics"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Cheng, H., Zhang, Q., Zhong, W., Li, H., Wang, L., Wang, S., He, C., Fu, C., and Wei, Q. (2025). Pulsed electromagnetic fields inhibit atherosclerosis by regulating pyroptosis through membrane tension-mediated mechanosensitive channels. Signal Transduct. Target. Ther., 10.","DOI":"10.1038\/s41392-025-02479-2"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.immuni.2025.01.003","article-title":"A cis-regulatory element controls expression of histone deacetylase 9 to fine-tune inflammasome-dependent chronic inflammation in atherosclerosis","volume":"58","author":"Asare","year":"2025","journal-title":"Immunity"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.123.065344","article-title":"BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis","volume":"148","author":"Yalcinkaya","year":"2023","journal-title":"Circulation"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/CIRCRESAHA.121.318908","article-title":"Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis","volume":"129","author":"Qiao","year":"2021","journal-title":"Circ. Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/eurheartj\/ehaf602","article-title":"Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease","volume":"47","author":"Adkar","year":"2026","journal-title":"Eur. Heart J."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.kint.2025.04.016","article-title":"The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2\/NLRP3 inflammasome signaling pathway","volume":"108","author":"Fu","year":"2025","journal-title":"Kidney Int."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/s41590-025-02230-7","article-title":"The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets","volume":"26","author":"Weber","year":"2025","journal-title":"Nat. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.abi5934","article-title":"Dying cells fan the flames of inflammation","volume":"374","author":"Newton","year":"2021","journal-title":"Science"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jare.2025.04.029","article-title":"Resibufogenin protects against atherosclerosis in ApoE-\/- mice through blocking NLRP3 inflammasome assembly","volume":"80","author":"Xiaoyang","year":"2026","journal-title":"J. Adv. Res."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Shang, J., Ma, Y., Liu, X., Sun, S., Pang, X., Zhou, R., Huan, S., He, Y., Xiong, B., and Zhang, X.-B. (2024). Single-particle rotational microrheology enables pathological staging of macrophage foaming and antiatherosclerotic studies. Proc. Natl. Acad. Sci. USA, 121.","DOI":"10.1073\/pnas.2403740121"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cvr\/cvac189","article-title":"Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1\u03b2 secretion","volume":"119","author":"Yalcinkaya","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/CIRCRESAHA.123.323699","article-title":"Orphan Nuclear Receptor NR4A3 Promotes Vascular Calcification via Histone Lactylation","volume":"134","author":"Ma","year":"2024","journal-title":"Circ. Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.molcel.2023.04.017","article-title":"LKB1 controls inflammatory potential through CRTC2-dependent histone acetylation","volume":"83","author":"Compton","year":"2023","journal-title":"Mol. Cell"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Zhu, X., Chen, Z., Shen, W., Huang, G., Sedivy, J.M., Wang, H., and Ju, Z. (2021). Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: The regulation and intervention. Signal Transduct. Target. Ther., 6.","DOI":"10.1038\/s41392-021-00646-9"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/CIRCULATIONAHA.125.072576","article-title":"Histone Lactylation-Mediated Metabolic Remodeling in Vascular Smooth Muscle Cells Aggravates Aortic Aneurysm and Dissection by Promoting Lactate Accumulation","volume":"153","author":"Liu","year":"2026","journal-title":"Circulation"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/eurheartj\/ehaf493","article-title":"Arachidonic acid fuels inflammation by unlocking macrophage protein phosphatase 5 after myocardial infarction","volume":"47","author":"Chen","year":"2026","journal-title":"Eur. Heart J."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.123.065597","article-title":"Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation","volume":"149","author":"Lin","year":"2024","journal-title":"Circulation"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Sohn, H.A., Go, H., An, T.H., Lee, J.M., Kim, H.-J., Haam, K., Magdy, A., Jung, H.-J., Shin, Y.-J., and Lim, H.J. (2026). DNMT1 Facilitates the Progression of MASLD by Impeding Transcription Mediated by HNF4\u03b1 and PPAR\u03b1. Clin. Mol. Hepatol.","DOI":"10.3350\/cmh.2025.1099"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/CIRCRESAHA.121.318836","article-title":"Epigenetic Regulation of F2RL3 Associates With Myocardial Infarction and Platelet Function","volume":"130","author":"Corbin","year":"2022","journal-title":"Circ. Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s42255-022-00575-z","article-title":"Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics","volume":"4","author":"Liu","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2026.01.004","article-title":"Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytes","volume":"59","author":"Grassmann","year":"2026","journal-title":"Immunity"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.121.057599","article-title":"Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity","volume":"145","author":"Chakraborty","year":"2022","journal-title":"Circulation"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Li, H., Shang, Z., Shen, A., Huang, X., Lu, A., Zhang, Z., Liu, T., Lin, G., Peng, Y., and Wei, Y. (2025). Panax notoginseng saponin mitigates glycolysis to regulate macrophage polarization and sphingolipid metabolism via hypoxia-inducible factor-1 to alleviate atherosclerosis. Phytomedicine, 149.","DOI":"10.1016\/j.phymed.2025.157506"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"34171","DOI":"10.1021\/acsnano.4c10739","article-title":"NIR-II Imaging for Tracking the Spatiotemporal Immune Microenvironment in Atherosclerotic Plaques","volume":"18","author":"Shen","year":"2024","journal-title":"ACS Nano"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Yu, B., Wang, X., Song, Y., Xie, G., Jiao, S., Shi, L., Cao, X., Han, X., and Qu, A. (2022). The role of hypoxia-inducible factors in cardiovascular diseases. Pharmacol. Ther., 238.","DOI":"10.1016\/j.pharmthera.2022.108186"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7150\/ijbs.77304","article-title":"TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury","volume":"19","author":"Zhong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Wang, M., Flaswinkel, H., Joshi, A., Napoli, M., Masgrau-Alsina, S., Kamper, J.M., Henne, A., Heinz, A., Berouti, M., and Schmacke, N.A. (2024). Phosphorylation of PFKL regulates metabolic reprogramming in macrophages following pattern recognition receptor activation. Nat. Commun., 15.","DOI":"10.1038\/s41467-024-50104-7"},{"key":"ref_212","first-page":"388","article-title":"Dual itaconate delivery systems modulate macrophage Acod1-Hif-1\u03b1-glycolysis axis for immunotherapy of bioprosthetic heart valve calcification","volume":"58","author":"Wen","year":"2026","journal-title":"Bioact. Mater."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s44161-024-00585-y","article-title":"Mechanical regulation of macrophage metabolism by allograft inflammatory factor 1 leads to adverse remodeling after cardiac injury","volume":"4","author":"DeBerge","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Huang, H., Li, G., He, Y., Chen, J., Yan, J., Zhang, Q., Li, L., and Cai, X. (2024). Cellular succinate metabolism and signaling in inflammation: Implications for therapeutic intervention. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1404441"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Xu, J., Tian, Z., Li, Z., Du, X., Cui, Y., Wang, J., Gao, M., and Hou, Y. (2023). Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate\/HIF-1\u03b1\/IL-1\u03b2 axis. J. Ethnopharmacol., 317.","DOI":"10.1016\/j.jep.2023.116675"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Zhu, W., Chen, Z., Gao, Y., Zhai, C., Li, X., Wang, N., Fu, K., Chen, W., Peng, J., and Xu, D. (2025). Deficient chaperone-mediated autophagy in macrophages aggravates colitis and colitis-associated tumorigenesis in mice. Mol. Cells, 48.","DOI":"10.1016\/j.mocell.2025.100298"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Thomas, C., Leleu, D., and Masson, D. (2022). Cholesterol and HIF-1\u03b1: Dangerous Liaisons in Atherosclerosis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.868958"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Chen, S., Zhang, W., Tang, C., Rong, X., Liu, Y., Luo, Y., Xu, L., Xu, Z., Wang, J., and Wang, Y. (2024). Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-02939-x"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehaf645","article-title":"Do obesity and visceral adiposity promote heart failure with reduced ejection fraction?","volume":"47","author":"Packer","year":"2026","journal-title":"Eur. Heart J."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/cvr\/cvaf056","article-title":"The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction","volume":"121","author":"Eringa","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/ejhf.2741","article-title":"Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: Mechanisms, management and modern perspectives","volume":"24","author":"Westenbrink","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Nogajski, \u0141., Mazuruk, M., Kacperska, M., Kurpias, M., M\u0105czewski, M., Nowakowski, M., M\u0105czewski, M., Micha\u0142owska, I., Leszek, P., and Paterek, A. (2024). Epicardial fat density obtained with computed tomography imaging\u2014More important than volume?. Cardiovasc. Diabetol., 23.","DOI":"10.1186\/s12933-024-02474-x"},{"key":"ref_223","unstructured":"(2026, April 19). Deciphering Mechanisms of Cardiomyocytes and Non-Cardiomyocyte Transformation in Myocardial Remodeling of Permanent Atrial Fibrillation\u2014Search Results\u2014PubMed[EB\/OL], Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Deciphering+mechanisms+of+cardiomyocytes+and+non-cardiomyocyte+transformation+in+myocardial+remodeling+of+permanent+atrial+fibrillation&size=200."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction: A Novel Framework to Explain Pathogenesis and Guide Treatment","volume":"86","author":"Packer","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s44161-024-00532-x","article-title":"Tissue-resident memory T cells in epicardial adipose tissue comprise transcriptionally distinct subsets that are modulated in atrial fibrillation","volume":"3","author":"Vyas","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Song, Y.-J., Zhao, X.-Y., Wang, L.-J., Ning, T., Chen, M.-T., Liu, P., Chen, S.-W., and Zhao, X.-X. (2025). Epicardial Adipose Tissue and Heterogeneity Parameters Combined with Inflammatory Cells to Predict the Value of Heart Failure with Preserved Ejection Fraction Patients Post Myocardial Infarction. Cardiovasc. Diabetol., 24.","DOI":"10.1186\/s12933-025-02720-w"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Menghoum, N., Badii, M.C., Leroy, M., Parra, M., Roy, C., Lejeune, S., Vancraeynest, D., Pasquet, A., Brito, D., and Casadei, B. (2025). Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction. Cardiovasc. Diabetol., 24.","DOI":"10.1186\/s12933-025-02688-7"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Overgaard, K.S., Andersen, T.R., Heinsen, L.J., Pararajasingam, G., Mohamed, R.A., Madsen, F.S., Biesenbach, I.I.A., H\u00f8jlund, K., Lambrechtsen, J., and Auscher, S. (2025). Pericoronary adipose tissue attenuation predicts compositional plaque changes: A 12-month longitudinal study in individuals with type 2 diabetes without symptoms or known coronary artery disease. Cardiovasc. Diabetol., 24.","DOI":"10.1186\/s12933-025-02694-9"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Cinti, F., Leccisotti, L., Sorice, G.P., Capece, U., D\u2019Amario, D., Lorusso, M., Gugliandolo, S., Morciano, C., Guarneri, A., and Guzzardi, M.A. (2023). Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes. Cardiovasc. Diabetol., 22.","DOI":"10.1186\/s12933-023-02091-0"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Zhao, J., Cheng, W., Dai, Y., Li, Y., Feng, Y., Tan, Y., Xue, Q., Bao, X., Sun, X., and Kang, L. (2024). Excessive accumulation of epicardial adipose tissue promotes microvascular obstruction formation after myocardial ischemia\/reperfusion through modulating macrophages polarization. Cardiovasc. Diabetol., 23.","DOI":"10.1186\/s12933-024-02342-8"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Cheng, C.K., Ding, H., Jiang, M., Yin, H., Gollasch, M., and Huang, Y. (2023). Perivascular adipose tissue: Fine-tuner of vascular redox status and inflammation. Redox Biol., 62.","DOI":"10.1016\/j.redox.2023.102683"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wang, X., Chen, Y., Zhang, Y., Zhen, X., Tao, S., Dou, J., Li, P., and Jiang, G. (2024). Perivascular fat tissue and vascular aging: A sword and a shield. Pharmacol. Res., 203.","DOI":"10.1016\/j.phrs.2024.107140"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Man, A.W.C., Xia, N., and Li, H. (2025). Vascular effects of perivascular adipose tissue-derived chemerin in obesity-associated cardiovascular disease. Cardiovasc. Diabetol., 24.","DOI":"10.1186\/s12933-025-02814-5"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.freeradbiomed.2020.10.021","article-title":"Omentin: A novel therapeutic approach for the treatment of endothelial dysfunction in type 2 diabetes","volume":"162","author":"Leandro","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.ady8644","article-title":"Ablation of Prdm16 and beige fat identity causes vascular remodeling and elevated blood pressure","volume":"391","author":"Koenen","year":"2026","journal-title":"Science"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Adachi, Y., Ueda, K., Nomura, S., Ito, K., Katoh, M., Katagiri, M., Yamada, S., Hashimoto, M., Zhai, B., and Numata, G. (2022). Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling. Nat. Commun., 13.","DOI":"10.1038\/s41467-022-32658-6"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Hof, A., Landerer, M., Peitsmeyer, P., Herzog, R., Alber, J., Ahdab, M., Nettersheim, F.S., Mehrkens, D., Gei\u00dfen, S., and Braumann, S. (2025). Myeloperoxidase impacts vascular function by altering perivascular adipocytes\u2019 secretome and phenotype in obesity. Cell Rep. Med., 6.","DOI":"10.1016\/j.xcrm.2025.102087"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Li, J., Tian, Z., Zhang, T., Jin, J., Zhang, X., Xie, P., Lin, H., Gu, J., Wu, Y., and Wang, X. (2024). Single-cell view and a novel protective macrophage subset in perivascular adipose tissue in T2DM. Cell Mol. Biol. Lett., 29.","DOI":"10.1186\/s11658-024-00668-5"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2025.08.100","article-title":"The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and Treatment","volume":"86","author":"Khan","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13679-023-00519-y","article-title":"The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease","volume":"12","author":"Vachliotis","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Baars, T., Gieseler, R.K., Patsalis, P.C., and Canbay, A. (2022). Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease. Metabolism, 130.","DOI":"10.1016\/j.metabol.2022.155179"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCRESAHA.125.325492","article-title":"Decoding the Liver-Heart Axis in Cardiometabolic Diseases","volume":"136","author":"Capone","year":"2025","journal-title":"Circ. Res."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-025-01150-9","article-title":"Serum amyloid A in HFpEF and cardiometabolic diseases","volume":"121","author":"Liu","year":"2026","journal-title":"Basic Res. Cardiol."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Abohashem, S., Aldosoky, W., Abbasi, T., Dar, T., Rollings, R., Tung, B., Hammad, B., Saeed, F., Ali, A., and Takx, R.A.P. (2026). Hepatic steatosis associates with leukopoietic activity and atherosclerotic inflammation: Mechanistic insights into cardiovascular risk. Metabolism, 174.","DOI":"10.1016\/j.metabol.2025.156427"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Mooring, M., Yeung, G.A., Luukkonen, P., Liu, S., Akbar, M.W., Zhang, G.J., Balogun, O., Yu, X., Mo, R., and Nejak-Bowen, K. (2023). Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis. Sci. Transl. Med., 15.","DOI":"10.1126\/scitranslmed.ade3157"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4093\/dmj.2025.0184","article-title":"Extracellular Vesicle-Mediated Network in the Pathogenesis of Obesity, Diabetes, Steatotic Liver Disease, and Cardiovascular Disease","volume":"49","author":"Lee","year":"2025","journal-title":"Diabetes Metab. J."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Shu, B., Chen, X., Liu, Z., Tang, H., Yang, B., and Fu, C. (2025). Pleiotropic effects of SGLT2 inhibitors: A focus on macrophage-mediated action. Pharmacol. Res., 222.","DOI":"10.1016\/j.phrs.2025.108046"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"e940","DOI":"10.1161\/CIR.0000000000001404","article-title":"American Heart Association Molecular Determinants of Cardiovascular Health Committee of the Council on Genomic and Precision Medicine and Council on Epidemiology and Prevention; et al. Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association","volume":"153","author":"Rhee","year":"2026","journal-title":"Circulation"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41577-023-00843-3","article-title":"Clonal haematopoiesis and dysregulation of the immune system","volume":"23","author":"Belizaire","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Zhang, J.-L., Tong, S.-L., Zhuang, Q.-Q., Jin, S.-J., Li, J.-Q., and Sun, J. (2025). Clonal hematopoiesis of indeterminate potential: A multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases. Mil. Med. Res., 12.","DOI":"10.1186\/s40779-025-00654-8"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIRCRESAHA.124.324492","article-title":"Experimental TET2 Clonal Hematopoiesis Predisposes to Renal Hypertension Through an Inflammasome-Mediated Mechanism","volume":"135","author":"Polizio","year":"2024","journal-title":"Circ. Res."},{"key":"ref_252","first-page":"270","article-title":"Monascus pigment-protected bone marrow-derived stem cells for heart failure treatment","volume":"42","author":"Yue","year":"2024","journal-title":"Bioact. Mater."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.051775","article-title":"Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women","volume":"143","author":"Honigberg","year":"2021","journal-title":"Circulation"},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"McClatchy, J., Strogantsev, R., Wolfe, E., Lin, H.Y., Mohammadhosseini, M., Davis, B.A., Eden, C., Goldman, D., Fleming, W.H., and Conley, P. (2023). Clonal hematopoiesis related TET2 loss-of-function impedes IL1\u03b2-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells. Nat. Commun., 14.","DOI":"10.1038\/s41467-023-43697-y"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCULATIONAHA.124.073527","article-title":"miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction","volume":"153","author":"Zhang","year":"2026","journal-title":"Circulation"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/CIRCULATIONAHA.124.069420","article-title":"Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction","volume":"151","author":"Lv","year":"2025","journal-title":"Circulation"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2025.09.1508","article-title":"Does Colchicine Reduce Both Inflammation and Clonal Hematopoiesis in Atherosclerotic Cardiovascular Disease?","volume":"86","author":"Tardif","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2022.12.001","article-title":"Clonal hematopoiesis and inflammation\u2014The perpetual cycle","volume":"33","author":"Avagyan","year":"2023","journal-title":"Trends Cell Biol."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Chen, A.-T., Zhang, J., and Zhang, Y. (2023). Gut microbiota in heart failure and related interventions. Imeta, 2.","DOI":"10.1002\/imt2.125"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/prd.12433","article-title":"Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia","volume":"89","author":"Pussinen","year":"2022","journal-title":"Periodontol. 2000"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aba3683","article-title":"High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide","volume":"373","author":"Yoo","year":"2021","journal-title":"Science"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCRESAHA.125.325516","article-title":"Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure","volume":"136","author":"Snelson","year":"2025","journal-title":"Circ. Res."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Yang, Y., Zhang, H., Wang, Y., Xu, J., Shu, S., Wang, P., Ding, S., Huang, Y., Zheng, L., and Yang, Y. (2024). Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota. Imeta, 3.","DOI":"10.1002\/imt2.159"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-025-09263-w","article-title":"Imidazole propionate is a driver and therapeutic target in atherosclerosis","volume":"645","author":"Mastrangelo","year":"2025","journal-title":"Nature"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/gutjnl-2025-335610","article-title":"Gut microbiota and atherosclerosis","volume":"75","author":"Fusco","year":"2026","journal-title":"Gut"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/s42255-025-01413-8","article-title":"Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control","volume":"7","author":"Chilloux","year":"2025","journal-title":"Nat. Metab."},{"key":"ref_267","first-page":"e20","article-title":"Gut Microbiota Metabolites Sensed by Host GPR41\/43 Protect Against Hypertension","volume":"136","author":"Zheng","year":"2025","journal-title":"Circ. Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41581-022-00654-0","article-title":"The gut microbiome and hypertension","volume":"19","author":"Zheng","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.chom.2022.09.004","article-title":"Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation","volume":"30","author":"Tian","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/CIRCRESAHA.124.325079","article-title":"Intestinal Microbiota Contributes to the Development of Cardiovascular Inflammation and Vasculitis in Mice","volume":"136","author":"Jena","year":"2025","journal-title":"Circ. Res."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/CIRCRESAHA.122.320771","article-title":"Gut Dysbiosis Promotes Preeclampsia by Regulating Macrophages and Trophoblasts","volume":"131","author":"Jin","year":"2022","journal-title":"Circ. Res."},{"key":"ref_272","doi-asserted-by":"crossref","unstructured":"Chajadine, M., Laurans, L., Radecke, T., Mouttoulingam, N., Al-Rifai, R., Bacquer, E., Delaroque, C., Rytter, H., Bredon, M., and Knosp, C. (2024). Harnessing intestinal tryptophan catabolism to relieve atherosclerosis in mice. Nat. Commun., 15.","DOI":"10.1038\/s41467-024-50807-x"},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Huang, R., Shen, Z.-Y., Huang, D., Zhao, S.-H., Dan, L.-X., Wu, P., Tang, Q.-Z., and Ma, Z.-G. (2025). Microbiota-indole-3-propionic acid-heart axis mediates the protection of leflunomide against \u03b1PD1-induced cardiotoxicity in mice. Nat. Commun., 16.","DOI":"10.1038\/s41467-025-58107-8"},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Zhang, H., Wang, J., Shen, J., Chen, S., Yuan, H., Zhang, X., Liu, X., Yu, Y., Li, X., and Gao, Z. (2024). Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia\/reperfusion injury. Imeta, 3.","DOI":"10.1002\/imt2.220"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7150\/ijbs.84153","article-title":"Irisin attenuates vascular remodeling in hypertensive mice induced by Ang II by suppressing Ca2+-dependent endoplasmic reticulum stress in VSMCs","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Pan, J.-A., Zhang, H., Lin, H., Gao, L., Zhang, H.-L., Zhang, J.-F., Wang, C.-Q., and Gu, J. (2021). Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells. Redox Biol., 46.","DOI":"10.1016\/j.redox.2021.102120"},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Tang, Y.-J., Zhang, Z., Yan, T., Chen, K., Xu, G.-F., Xiong, S.-Q., Wu, D.-Q., Chen, J., Jose, P.A., and Zeng, C.-Y. (2024). Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53. Cardiovasc. Diabetol., 23.","DOI":"10.1186\/s12933-024-02183-5"},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Gumpper-Fedus, K., Park, K.H., Ma, H., Zhou, X., Bian, Z., Krishnamurthy, K., Sermersheim, M., Zhou, J., Tan, T., and Li, L. (2022). MG53 preserves mitochondrial integrity of cardiomyocytes during ischemia reperfusion-induced oxidative stress. Redox Biol., 54.","DOI":"10.1016\/j.redox.2022.102357"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1093\/eurheartj\/ehac431","article-title":"Exerkine fibronectin type-III domain-containing protein 5\/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability","volume":"43","author":"Chi","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.neuron.2023.08.012","article-title":"Irisin reduces amyloid-\u03b2 by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling","volume":"111","author":"Kim","year":"2023","journal-title":"Neuron"},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Szaroszyk, M., Kattih, B., Martin-Garrido, A., Trogisch, F.A., Dittrich, G.M., Grund, A., Abouissa, A., Derlin, K., Meier, M., and Holler, T. (2022). Skeletal muscle derived Musclin protects the heart during pathological overload. Nat. Commun., 13.","DOI":"10.1038\/s41467-021-27634-5"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jshs.2020.11.010","article-title":"Dynamic resistance exercise increases skeletal muscle-derived FSTL1 inducing cardiac angiogenesis via DIP2A-Smad2\/3 in rats following myocardial infarction","volume":"10","author":"Xi","year":"2021","journal-title":"J. Sport Health Sci."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Yin, A., Yuan, R., Xiao, Q., Zhang, W., Xu, K., Yang, X., Yang, W., Xu, L., Wang, X., and Zhuang, F. (2022). Exercise-derived peptide protects against pathological cardiac remodeling. EBioMedicine, 82.","DOI":"10.1016\/j.ebiom.2022.104164"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehae827","article-title":"Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes","volume":"46","author":"Souza","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ejhf.3192","article-title":"Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction","volume":"26","author":"Wood","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_286","doi-asserted-by":"crossref","unstructured":"Ying, L., Wang, L., Guo, K., Hou, Y., Li, N., Wang, S., Liu, X., Zhao, Q., Zhou, J., and Zhao, L. (2021). Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects. Nat. Commun., 12.","DOI":"10.1038\/s41467-021-27584-y"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1021\/acsnano.5c18226","article-title":"Muscle-Targeted Nanocomposite Therapy Alleviates Age-Related Sarcopenia via Antioxidant and Metabolic Reprogramming","volume":"20","author":"Liu","year":"2026","journal-title":"ACS Nano"},{"key":"ref_288","doi-asserted-by":"crossref","unstructured":"Flensted-Jensen, M., Weinreich, C.M., Kleis-Olsen, A.-S., Hansen, F., Skyggelund, N.S., Pii, J.R., Whitlock, R., Karlsen, A., Ingersen, A., and Reihmane, D. (2026). Resistance-based training improves mitochondrial capacity and redox balance in aging adults, independent of polyphenol supplementation. Redox Biol., 89.","DOI":"10.1016\/j.redox.2025.103972"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s43587-024-00797-8","article-title":"Multi-omic profiling of sarcopenia identifies disrupted branched-chain amino acid catabolism as a causal mechanism and therapeutic target","volume":"5","author":"Zuo","year":"2025","journal-title":"Nat. Aging"},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"Laurila, P.-P., Luan, P., Wohlwend, M., Zanou, N., Crisol, B., Imamura de Lima, T., Goeminne, L.J.E., Gallart-Ayala, H., Shong, M., and Ivanisevic, J. (2022). Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy. Sci. Adv., 8.","DOI":"10.1126\/sciadv.abh4423"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.7150\/thno.54498","article-title":"Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: From pharmacology to pre-clinical and clinical therapeutics","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-med-080819-044918","article-title":"Treating Coronary Artery Disease: Beyond Statins, Ezetimibe, and PCSK9 Inhibition","volume":"72","author":"Musunuru","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"ref_293","doi-asserted-by":"crossref","unstructured":"Zheng, R., Song, W., Lu, J., Yuan, M., Sun, X., and Lu, C. (2025). The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus. Cardiovasc. Diabetol., 24.","DOI":"10.1186\/s12933-025-02600-3"},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Ye, M., Feng, S., Xu, Z., He, W., Liu, C., and Zhu, W. (2026). Aging and metabolism in HFpEF: Pathophysiology and therapeutic implications. Metabolism, 176.","DOI":"10.1016\/j.metabol.2025.156460"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium\/Glucose Cotransporter 2 Inhibitor Empagliflozin","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.7150\/ijbs.59965","article-title":"GLP-1 receptor agonists (GLP-1RAs): Cardiovascular actions and therapeutic potential","volume":"17","author":"Ma","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_297","doi-asserted-by":"crossref","unstructured":"Luna-Marco, C., de Mara\u00f1on, A.M., Hermo-Argibay, A., Rodriguez-Hernandez, Y., Hermenejildo, J., Fernandez-Reyes, M., Apostolova, N., Vila, J., Sola, E., and Morillas, C. (2023). Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes. Redox Biol., 66.","DOI":"10.1016\/j.redox.2023.102849"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.kint.2023.09.029","article-title":"Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation","volume":"105","author":"Sourris","year":"2024","journal-title":"Kidney Int."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/cvr\/cvab065","article-title":"Metformin again? Atheroprotection mediated by macrophage AMPK and ATF1","volume":"117","author":"Salt","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s42255-024-00999-9","article-title":"Lac-Phe mediates the effects of metformin on food intake and body weight","volume":"6","author":"Xiao","year":"2024","journal-title":"Nat. Metab."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory Action of Statins in Cardiovascular Disease: The Role of Inflammasome and Toll-Like Receptor Pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s44161-022-00023-x","article-title":"The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis","volume":"1","author":"Jarr","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-med-100119-013612","article-title":"New Approaches for the Prevention and Treatment of Cardiovascular Disease: Focus on Lipoproteins and Inflammation","volume":"72","author":"Hussain","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in Atherosclerosis-No Longer a Theory","volume":"67","author":"Libby","year":"2021","journal-title":"Clin. Chem."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ehjcvp\/pvad005","article-title":"The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes","volume":"9","author":"Johansen","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1182\/bloodadvances.2023011578","article-title":"Effects of IL-1\u03b2 inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial","volume":"7","author":"Woo","year":"2023","journal-title":"Blood Adv."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.053318","article-title":"Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial","volume":"143","author":"Meyer","year":"2021","journal-title":"Circulation"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Orkaby, A.R., Thomson, A., MacFadyen, J., Besdine, R., Forman, D.E., Travison, T.G., and Ridker, P.M. (2024). Effect of canakinumab on frailty: A post hoc analysis of the CANTOS trial. Aging Cell, 23.","DOI":"10.1111\/acel.14029"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tcm.2020.10.007","article-title":"Colchicine for the treatment of coronary artery disease","volume":"31","author":"Aimo","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/joim.70012","article-title":"Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study","volume":"298","author":"Jeon","year":"2025","journal-title":"J. Intern. Med."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pcad.2025.08.010","article-title":"Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients","volume":"92","author":"Jaiswal","year":"2025","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_315","doi-asserted-by":"crossref","unstructured":"Bao, R.-H., Zhao, N., Jiang, X.-F., Cong, Z.-H., Liu, J., Kang, L.-D., Chen, Y.-H., Sun, J.-N., Xing, W.-Y., and Liu, J.-X. (2025). Balancing the benefits and risks of colchicine use among patients with atherosclerotic cardiovascular disease: An umbrella review of meta-analyses of randomised controlled trials. EClinicalMedicine, 84.","DOI":"10.1016\/j.eclinm.2025.103277"},{"key":"ref_316","first-page":"68","article-title":"Colchicine and plaque: A focus on atherosclerosis imaging","volume":"84","author":"Golub","year":"2024","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_317","doi-asserted-by":"crossref","unstructured":"Bates, E.R. (2024). In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo. Ann. Intern. Med., 177.","DOI":"10.7326\/J24-0026"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/eurjpc\/zwae355","article-title":"The effects of colchicine on lipoprotein(a)- and oxidized phospholipid-associated cardiovascular disease risk","volume":"32","author":"Mohammadnia","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/eurheartj\/ehaf210","article-title":"Colchicine for secondary prevention of vascular events: A meta-analysis of trials","volume":"46","author":"Poorthuis","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_320","doi-asserted-by":"crossref","unstructured":"Cole, J., Htun, N., Lew, R., Freilich, M., Quinn, S., and Layland, J. (2021). Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial. Circ. Cardiovasc. Interv., 14.","DOI":"10.1161\/CIRCINTERVENTIONS.120.009992"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.20107","article-title":"Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials","volume":"298","author":"Xie","year":"2025","journal-title":"J. Intern. Med."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.125.073919","article-title":"Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants","volume":"152","author":"Gasperetti","year":"2025","journal-title":"Circulation"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jamacardio.2025.4603","article-title":"Clonal Hematopoiesis and Incident Heart Failure","volume":"11","author":"Flynn","year":"2026","journal-title":"JAMA Cardiol."},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"Li, X., Li, D., Liu, S., Wang, Y., Fan, X., Yan, Z., Tan, S., Zhuang, P., and Zhang, Y. (2025). Shenfu injection inhibits myocardial fibrosis by regulating glycolysis through the PI3K-AKT\/HIF-1\u03b1 signaling pathway. Phytomedicine, 149.","DOI":"10.1016\/j.phymed.2025.157529"},{"key":"ref_325","doi-asserted-by":"crossref","unstructured":"Rihan, M., and Sharma, S.S. (2024). Compound 3K attenuates isoproterenol-induced cardiac hypertrophy by inhibiting pyruvate kinase M2 (PKM2) pathway. Life Sci., 351.","DOI":"10.1016\/j.lfs.2024.122837"},{"key":"ref_326","doi-asserted-by":"crossref","unstructured":"Crespo-Avilan, G.E., Hernandez-Resendiz, S., Ramachandra, C.J., Ungureanu, V., Lin, Y.-H., Lu, S., Bernhagen, J., El Bounkari, O., Preissner, K.T., and Liehn, E.A. (2024). Metabolic reprogramming of immune cells by mitochondrial division inhibitor-1 to prevent post-vascular injury neointimal hyperplasia. Atherosclerosis, 390.","DOI":"10.1016\/j.atherosclerosis.2024.117450"},{"key":"ref_327","doi-asserted-by":"crossref","unstructured":"Mosalmanzadeh, N., Maurmann, R.M., Davis, K., Schmitt, B.L., Makowski, L., and Pence, B.D. (2024). Modulatory Effects of Mdivi-1 on OxLDL-Induced Metabolic Alterations, Inflammatory Responses, and Foam Cell Formation in Human Monocytes. bioRxiv, bioRxiv:2024.12.12.628145.","DOI":"10.1101\/2024.12.12.628145"},{"key":"ref_328","doi-asserted-by":"crossref","unstructured":"Liu, Y., Tang, X., Yuan, H., and Gao, R. (2024). Naringin Inhibits Macrophage Foam Cell Formation by Regulating Lipid Homeostasis and Metabolic Phenotype. Nutrients, 16.","DOI":"10.3390\/nu16091321"},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Ma, C., Hua, Y., Yang, S., Zhao, Y., Zhang, W., Miao, Y., Zhang, J., Feng, B., Zheng, G., and Li, L. (2025). Wogonin Attenuates Atherosclerosis via KLF11-Mediated Suppression of PPAR\u03b1-YAP1-Driven Glycolysis and Enhancement of ABCA1\/G1-Mediated Cholesterol Efflux. Adv. Sci., 12.","DOI":"10.1002\/advs.202500610"},{"key":"ref_330","doi-asserted-by":"crossref","unstructured":"Ma, Y., Feng, S., Jiang, Y., Jiang, J., Liu, R., Ma, Y., Yin, X., Bian, H., and Zhu, R. (2026). SLC22A6-dependent lactylation of H3K9 aggravates endothelial dysfunction and atherosclerosis. Metabolism, 175.","DOI":"10.1016\/j.metabol.2025.156426"},{"key":"ref_331","doi-asserted-by":"crossref","unstructured":"Hou, H., Meng, J., Chen, Y., Zhang, X., Yang, Z., Wang, Q., Zheng, M., and Jiang, Z. (2025). PRMT3 at the crossroads of inflammation: Dual roles in metabolic reprogramming and immune dysregulation in chronic diseases. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1663258"},{"key":"ref_332","doi-asserted-by":"crossref","unstructured":"Xie, L., Cheng, Y., Du, W., Fu, L., Wei, Z., Guan, Y., Wang, Y., Mei, C., Hao, C., and Chen, M. (2023). Activation of GPER1 in macrophages ameliorates UUO-induced renal fibrosis. Cell Death Dis., 14.","DOI":"10.1038\/s41419-023-06338-2"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cmet.2021.11.003","article-title":"Cysteine 253 of UCP1 regulates energy expenditure and sex-dependent adipose tissue inflammation","volume":"34","author":"Mills","year":"2022","journal-title":"Cell Metab."},{"key":"ref_334","doi-asserted-by":"crossref","unstructured":"Sakkers, T.R., Mili, E., Winter, H., Kapteijn, D., Perry, R.N., Barbera, N., Watts, K., Dias, I.R., Meteva, D., and Wesseling, M. (2026). Atherosclerotic Fibrous Plaques in Women Present ECM Remodeling Linked to TGF-\u03b2. Circ. Res., 138.","DOI":"10.1161\/CIRCRESAHA.125.327624"},{"key":"ref_335","doi-asserted-by":"crossref","unstructured":"Pietropaoli, D., Altamura, S., Ortu, E., Guerrini, L., Pizarro, T.T., Ferri, C., and Del Pinto, R. (2023). Association between metabolic syndrome components and gingival bleeding is women-specific: A nested cross-sectional study. J. Transl. Med., 21.","DOI":"10.1186\/s12967-023-04072-z"},{"key":"ref_336","doi-asserted-by":"crossref","unstructured":"Mishra, A., Wang, Y., Yin, F., Vitali, F., Rodgers, K.E., Soto, M., Mosconi, L., Wang, T., and Brinton, R.D. (2022). A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer\u2019s prevention & treatment. Ageing Res. Rev., 74.","DOI":"10.1016\/j.arr.2021.101542"},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/cvr\/cvab096","article-title":"Clinical efficacy and safety of angiogenesis inhibitors: Sex differences and current challenges","volume":"118","author":"Cignarella","year":"2022","journal-title":"Cardiovasc. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5526\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:29:28Z","timestamp":1782534568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":337,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125526"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125526","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}